TargetMol

Calpeptin

Product Code:
 
TAR-T6432
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6432-5mg5mg£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6432-1mL1 mL * 10 mM (in DMSO)£116.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6432-10mg10mg£133.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6432-25mg25mg£202.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6432-50mg50mg£257.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6432-100mg100mg£371.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Calpeptin is a potent, cell-permeable calpain inhibitor.
CAS:
117591-20-5
Formula:
C20H30N2O4
Molecular Weight:
362.47
Pathway:
Proteases/Proteasome; Apoptosis; Ubiquitination
Purity:
0.9752
SMILES:
CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O
Target:
Apoptosis; Cysteine Protease; Proteasome

References

Chen Y, Chen L, Wu X, et al.Acute liver steatosis translationally controls the epigenetic regulator MIER1 to promote liver regeneration in a study with male mice.Nature Communications.2023, 14(1): 1521. Tian T, Xie X, Yi W, et al.FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation.Cell Reports.2023, 42(11). Pint?r M, et al. Neurosci Lett. 1994 Mar 28;170(1):91-3. Das A, et al. Brain Res. 2006, 1084(1), 146-157. Mani SK, et al. Am J Physiol Heart Circ Physiol. 2008, 295(1), H314-326. Tsujinaka T, et al. Biochem Biophys Res Commun. 1988, 153(3), 1201-1208. Peng S, et al. Mol Biol Rep. 2011, 38(2), 905-912.